Lotus Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Lotus Pharmaceutical has a total shareholder equity of NT$20.2B and total debt of NT$12.1B, which brings its debt-to-equity ratio to 60%. Its total assets and total liabilities are NT$37.2B and NT$17.0B respectively. Lotus Pharmaceutical's EBIT is NT$5.3B making its interest coverage ratio 10.9. It has cash and short-term investments of NT$3.7B.
Key information
60.0%
Debt to equity ratio
NT$12.13b
Debt
| Interest coverage ratio | 10.9x |
| Cash | NT$3.69b |
| Equity | NT$20.22b |
| Total liabilities | NT$17.02b |
| Total assets | NT$37.23b |
Recent financial health updates
Here's Why Lotus Pharmaceutical (TWSE:1795) Has A Meaningful Debt Burden
Oct 23
Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?
Apr 24These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively
Apr 04Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?
Dec 31Recent updates
Market Cool On Lotus Pharmaceutical Co., Ltd.'s (TWSE:1795) Earnings
Dec 04Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 16Lotus Pharmaceutical's (TWSE:1795) Earnings Are Weaker Than They Seem
Nov 14Here's Why Lotus Pharmaceutical (TWSE:1795) Has A Meaningful Debt Burden
Oct 23Lotus Pharmaceutical Co., Ltd. Just Missed Revenue By 5.2%: Here's What Analysts Think Will Happen Next
Aug 14Investors Continue Waiting On Sidelines For Lotus Pharmaceutical Co., Ltd. (TWSE:1795)
Jul 18Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?
Apr 24Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price
Apr 09Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals
Mar 22These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively
Apr 04Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 09Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?
Feb 11
Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?
Jan 21Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?
Dec 31I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease
Dec 10Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next
Nov 19Financial Position Analysis
Short Term Liabilities: 1795's short term assets (NT$15.6B) exceed its short term liabilities (NT$6.1B).
Long Term Liabilities: 1795's short term assets (NT$15.6B) exceed its long term liabilities (NT$10.9B).
Debt to Equity History and Analysis
Debt Level: 1795's net debt to equity ratio (41.8%) is considered high.
Reducing Debt: 1795's debt to equity ratio has reduced from 91.5% to 60% over the past 5 years.
Debt Coverage: 1795's debt is well covered by operating cash flow (38.1%).
Interest Coverage: 1795's interest payments on its debt are well covered by EBIT (10.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:41 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lotus Pharmaceutical Co., Ltd. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Capital Securities Corporation |
| Jianzheng Wu | Capital Securities Corporation |
| Hsuan Chen | KGI Securities Co. Ltd. |